ZV
ZyVersa Therapeutics, Inc.
ZVSA · OTC
$0.12 +16.16% (+$0.02)
1M +13.97%
Market Cap $918.1K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.14
21.7% upside
Trenutna cena
$0.12
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ZVSA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
0/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROIC 16.54%
ROA 3.30%
Debt
0 /100
High Int. coverage -46.93x
Current ratio 0.05x
Debt/Assets N/A
Stability
48 /100
Moderate Profitable years 0
Beta 0.87x
EPS volatility 58.45%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ZVSA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stephen C. Glover
Employees
6
Headquarters
Weston
Prihajajoči dogodki
18 NOV.
Earnings
Upcoming earnings report